维普中文期刊产品整合服务
30篇 您的检索式:作者名="Olszynski"
    题名 作者 年代 出处 被引量
1Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men:a prospective observational study显示文摘Olszynski WP Davison KS Ioannidis G 0,,02:1
2Fracture risk remains reduced one year after discontinuation of risedronate显示文摘Watts NB Chines A Olszynski WP McKeever CD McClung MR Zhou X Grauer A 0,,:1
3Effectiveness ofal- endronate and etidronate in the treatment of osteoporosis in men: a prospective observational study显示文摘Olszynski WP Davison KS Ioannidis G 2006Osteoporos Int2006,17,2:1
4Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment显示文摘Olszynski WP Shawn Davison K Adachi JD 2004Clin Ther2004,26,1:1
5Risedronate is well-tolerated in osteoporotic patients,including those over 80 years of age显示文摘Deal C Piette F Olszynski W 2000Arthritis Rheum2000,43,9:1
6Structure and function of matrix metalloproteinases显示文摘OLSZYNSKI K ZIMOWSKA M 2009Postepy Biochem2009,55,1:1
7Structure and function of matrix metalloprotein- ases 显示文摘Olszynski K Zimosk M 2009Postepy Biochem2009,55,1:1
8Structure and function of matrix metalloproteinases显示文摘OLSZYNSKI K ZIMOWSKA M 2009Postepy Biochem2009,55,1:1
9Muhisite quan- titative ultrasound for the prediction of fractures over 5 years of follow-up: the Canadian Muhicentre Osteoporosis Study显示文摘Olszynski WP Brown JP Adachi JD 2013J Bone Miner Res2013,28,9:1
10Structure and function of matrix metalloproteinases显示文摘Olszynski K Zimowska M 2009Postepy Biochem2009,55,1:1
11Assoeiation among disease conditions bone mineral density,and prevalent vertebral deformities in men and women 50 years of age and older;cross sectional results from the Canadian Multicentre Osteoporosis Study显示文摘Da Hanley Browm JP Tenenhouse A Olszynski WP Ioannidis G Berger C 0,,:1
12The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women 显示文摘Adachi J Ioannidis G Olszynski W 2002BMC Musculoskelet Disord2002,3,:1
13The incidence and prognosis of central nervous system disease in systemic lu pus erythematosus显示文摘 Olszynski WP Decoteau WF 1992J Rheumatol1992,19,:1
14Structure and function of matrix metallopreleinases显示文摘Olszynski K Zimowska M 2009postepy Biochem2009,55,1:1
15Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use显示文摘Anthony B. Hodsman Douglas C. Bauer David W. Dempster Larry Dian David A. Hanley Steven T. Harris David L. Kendler Michael R. McClung Paul D. Miller Wojciech P. Olszynski Eric Orwoll Chui Kin Yuen 2005Endocrine Reviews2005,,5:1
16Muhisite quanti- tative ultrasound for the prediction of fractures over 5 years of follow- up:the Canadian Muhicentre Osteoporosis Study 显示文摘Olszynski WP Brown JP Adachi JD 2013J Bone Miner Res2013,28,9:1
17The incidence and prognosis of central nervous system disease in systemic lupus erythematosus 显示文摘Sibley JT Olszynski WP Decoteau WE 1992J Rheumatol1992,,1:1
18Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study 显示文摘OLSZYNSKI W P DAVISON K S LOANNIDIS G 2006Osteoporos Int2006,17,2:1
19Structure and function of matrix metalloproteinases显示文摘Olszynski K Zimowska M 2009Postepy Biochem2009,55,1:1
20Associations among disease conditions,bone mineral density,and prevalent vertebral deformities in men and women 50 years of age and older:cross-sectional results from the Canadian Multicentre Osteoporosis Study显示文摘Hanley DA Brown JP Tenenhouse A Olszynski WP Ioannidis G Berger C Prior JC Pickard L Murray TM Anastassiades T Kirkland S Joyce C Joseph L Papaioannou A Jackson SA Poliquin S Adachi JD 0,,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费